Morningside Venture (VI) Investments

Morningside is a private investment group and venture capital firm founded in 1986 as the Chan family office. The organization invests globally in novel science and technology businesses, with a significant focus on life sciences, biotech, digital health, medtech, AI, and related sectors. The requested entity, Morningside Venture (VI) Investments Ltd, appears to be a legal investment vehicle associated with the broader Morningside platform rather than a standalone drug-development operating company. Morningside has backed numerous healthcare and biotechnology companies across North America, Europe, and Greater China. For biotech analysts, it is best understood as an active healthcare-focused investor with a broad private portfolio rather than as a therapeutics developer.